Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Morphosys Ag ADR (NQ: MOR ) 18.96 UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Morphosys Ag ADR < Previous 1 2 3 4 5 6 7 8 9 Next > 3 Global Stocks to Buy to Escape the Volatility on Wall Street July 16, 2024 Discover three top global stocks as a smart hedge against Wall Street volatility, offering diversification and resilience in uncertain times. Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session May 27, 2024 Via Benzinga MOR Stock Earnings: MorphoSys Misses EPS, Misses Revenue for Q1 2024 April 30, 2024 MOR stock results show that MorphoSys missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib April 29, 2024 MorphoSys faces safety concerns over pelabresib, a myelofibrosis treatment. Physicians report patients transitioning rapidly to acute myeloid leukemia. FDA alerted. Novartis acquisition proceeds... Via Benzinga Exposures Product Safety Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends April 23, 2024 Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow. Via Benzinga MorphoSys: Q4 Earnings Insights March 13, 2024 Via Benzinga Earnings Outlook For MorphoSys March 12, 2024 Via Benzinga Dow Plummets on Rising Bond Yields, MCD Earnings February 05, 2024 Via Talk Markets Topics Stocks Exposures US Equities Earnings Scheduled For March 13, 2024 March 13, 2024 Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. Via Benzinga 5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024 March 09, 2024 Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the... Via Talk Markets 3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise March 07, 2024 Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth. Via InvestorPlace Exit Now! 3 Biotech Stocks to Sell in February 2024 February 21, 2024 These biotech stocks to sell represent incredibly risky bets, amidst the sector's volatility and looming economic unpredictability. Via InvestorPlace Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B February 06, 2024 Novartis' €2.7 billion public takeover offer for MorphoSys, unlocking a promising oncology pipeline with pelabresib and tulmimetostat. Via Benzinga Biotech Stock MorphoSys Catapults 56% As Novartis Agrees To Buy It For $2.9 Billion February 05, 2024 Novartis will add to its cancer treatment pipeline with via the German biotech. Via Investor's Business Daily Why Is MorphoSys (MOR) Stock Up 50% Today? February 05, 2024 News of a potential takeout bid for any company usually leads to a big surge. That's what investors are seeing today with MOR stock. Via InvestorPlace Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session February 05, 2024 Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS... Via Benzinga MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer February 05, 2024 Novartis is in advanced talks to acquire MorphoSys and appears to be beating out Incyte Corporation which has also made an offer to acquire MorphoSys. MorphoSys produces a lymphoma drug, Monjuvi, sold... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session February 05, 2024 Via Benzinga Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday February 05, 2024 U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday. Via Benzinga Topics Stocks Exposures US Equities Philips Reports Q4 Results, Joins Ryanair And Other Big Stocks Moving Lower In Monday's Pre-Market Session January 29, 2024 U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Monday. Via Benzinga Topics Stocks Exposures US Equities Why Super Micro Computer Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket January 19, 2024 Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) rose sharply in pre-market trading after the company announced updated financial guidance for the second-quarter, which surpassed its previou Via Benzinga Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 19, 2024 Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 19, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 19, 2024 We're starting the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning! Via InvestorPlace iRobot, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session January 19, 2024 U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 100 points on Friday. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 16, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session January 16, 2024 Via Benzinga Why LQR House Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket January 16, 2024 Shares of LQR House Inc. (NASDAQ: LQR) rose sharply in pre-market trading. Borg's investor group has acquired a 20% stake in LQR House. LQR House shares jumped 16.1% to $4.25 in pre-market trading Here... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday January 16, 2024 We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning! Via InvestorPlace Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session January 16, 2024 U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.